{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:11:06Z","timestamp":1791591066789,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nature Science Foundation of Fujian Province of China","award":["2024J0112"],"award-info":[{"award-number":["2024J0112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11953-9","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:22:39Z","timestamp":1763547759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical spectrum of Talaromyces marneffei infections in HIV-negative patients: an 18-case series including a rare presentation with gastrointestinal onset, adrenal mass, and hemophagocytic lymphohistiocytosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiewei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"1","key":"11953_CR1","doi-asserted-by":"publisher","first-page":"e0005122","DOI":"10.1128\/cmr.00051-22","volume":"36","author":"F Wang","year":"2023","unstructured":"Wang F, Han R, Chen S. An overlooked and underrated endemic Mycosis-Talaromycosis and the pathogenic fungus Talaromyces marneffei. Clin Microbiol Rev. 2023;36(1):e0005122.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"11953_CR2","doi-asserted-by":"publisher","first-page":"E1618","DOI":"10.1016\/S2214-109X(21)00350-8","volume":"9","author":"S Narayanasamy","year":"2021","unstructured":"Narayanasamy S, Dat VQ, Thanh NT, Ly VT, Chan JFW, Yuen KY, Ning CY, Liang H, Li LH, Chowdhary A, et al. A global call for talaromycosis to be recognised as a neglected tropical disease. Lancet Glob Health. 2021;9(11):E1618\u201322.","journal-title":"Lancet Glob Health"},{"key":"11953_CR3","doi-asserted-by":"crossref","unstructured":"Guo J, Ning XQ, Ding JY, Zheng YQ, Shi NN, Wu FY, Lin YK, Shih HP, Ting HT, Liang G, et al. Anti-IFN-gamma autoantibodies underlie disseminated Talaromyces marneffei infections. J Exp Med. 2020;217(12).","DOI":"10.1084\/jem.20190502"},{"issue":"5\u20136","key":"11953_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11046-022-00659-0","volume":"187","author":"L Wang","year":"2022","unstructured":"Wang L, Luo Y, Li X, Li Y, Xia Y, He T, Huang Y, Xu Y, Yang Z, Ling J, et al. Talaromyces marneffei infections in 8 Chinese children with inborn errors of immunity. Mycopathologia. 2022;187(5\u20136):455\u201367.","journal-title":"Mycopathologia"},{"issue":"1","key":"11953_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12879-024-09351-8","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang S, Lou L, Ma S, Wang H, Rong L, Liu Y, Zhang K, Ai Q, Shi X. Disseminated Talaromyces marneffei infection initially presenting as cutaneous and subcutaneous lesion in an HIV-Negative renal transplant recipient: a case report and literature review. BMC Infect Dis. 2024;24(1):473.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"11953_CR6","first-page":"e19","volume":"5","author":"JF Chan","year":"2016","unstructured":"Chan JF, Lau SK, Yuen KY, Woo PC. Talaromyces (Penicillium) Marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5(3):e19.","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"11953_CR7","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1128\/JCM.39.12.4535-4540.2001","volume":"39","author":"SS Wong","year":"2001","unstructured":"Wong SS, Wong KH, Hui WT, Lee SS, Lo JY, Cao L, Yuen KY. Differences in clinical and laboratory diagnostic characteristics of penicilliosis Marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol. 2001;39(12):4535\u201340.","journal-title":"J Clin Microbiol"},{"key":"11953_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijid.2023.04.398","volume":"132","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Liu AL, Huang J, Zeng W, Yang ZM, Fang GN, Li Y, Zhang YZ, Liang JK, Liu J, et al. Comparison of the clinical features of HIV-positive and HIV-negative hosts infected with Talaromyces marneffei: A multicenter, retrospective study. Int J Infect Dis. 2023;132:93\u20138.","journal-title":"Int J Infect Dis"},{"key":"11953_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/1471-2334-13-464","volume":"13","author":"R Kawila","year":"2013","unstructured":"Kawila R, Chaiwarith R, Supparatpinyo K. Clinical and laboratory characteristics of penicilliosis Marneffei among patients with and without HIV infection in Northern thailand: a retrospective study. BMC Infect Dis. 2013;13:464.","journal-title":"BMC Infect Dis"},{"key":"11953_CR10","doi-asserted-by":"publisher","first-page":"1038354","DOI":"10.3389\/fimmu.2022.1038354","volume":"13","author":"H Yan","year":"2022","unstructured":"Yan H, Mo Y, Liu S, Luo X, Liu L, Zhou L, Zhang X, Chen Y, Cao K. Case report: hemophagocytic lymphohistiocytosis in a child with primary immunodeficiency infected with Talaromyces marneffei. Front Immunol. 2022;13:1038354.","journal-title":"Front Immunol"},{"key":"11953_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12879-015-0782-6","volume":"15","author":"Y Qiu","year":"2015","unstructured":"Qiu Y, Zhang J, Liu G, Zhong X, Deng J, He Z, Jing B. Retrospective analysis of 14 cases of disseminated penicillium Marneffei infection with osteolytic lesions. BMC Infect Dis. 2015;15:47.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"11953_CR12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, et al. 2019 European league against Rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"11953_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5858\/2004-128-191-CSOHPM","volume":"128","author":"A Yousukh","year":"2004","unstructured":"Yousukh A, Jutavijittum P, Pisetpongsa P, Chitapanarux T, Thongsawat S, Senba M, Toriyama K. Clinicopathologic study of hepatic penicillium Marneffei in Northern Thailand. Arch Pathol Lab Med. 2004;128(2):191\u20134.","journal-title":"Arch Pathol Lab Med"},{"key":"11953_CR14","doi-asserted-by":"crossref","unstructured":"Barros N, Wheat JL, Hage C. Pulmonary histoplasmosis: a clinical update. J Fungi (Basel). 2023;9(2).","DOI":"10.3390\/jof9020236"},{"issue":"9","key":"11953_CR15","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1111\/jth.14946","volume":"18","author":"A Squizzato","year":"2020","unstructured":"Squizzato A, Gallo A, Levi M, Iba T, Levy JH, Erez O, Ten Cate H, Solh Z, Gando S, Vicente V, et al. Underlying disorders of disseminated intravascular coagulation: communication from the ISTH SSC subcommittees on disseminated intravascular coagulation and perioperative and critical care thrombosis and hemostasis. J Thromb Haemost. 2020;18(9):2400\u20137.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"11953_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"11953_CR17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/myc.13295","volume":"64","author":"L He","year":"2021","unstructured":"He L, Mei X, Lu S, Ma J, Hu Y, Mo D, Chen X, Fan R, Xi L, Xie T. Talaromyces marneffei infection in non-HIV-infected patients in mainland China. Mycoses. 2021;64(10):1170\u20136.","journal-title":"Mycoses"},{"key":"11953_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.micpath.2017.01.026","volume":"105","author":"Y Li","year":"2017","unstructured":"Li Y, Lin Z, Shi X, Mo L, Li W, Mo W, Yang Z. Retrospective analysis of 15 cases of penicillium Marneffei infection in HIV-positive and HIV-negative patients. Microb Pathog. 2017;105:321\u20135.","journal-title":"Microb Pathog"},{"issue":"7\u20138","key":"11953_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11046-017-0127-7","volume":"182","author":"P Wang","year":"2017","unstructured":"Wang P, Chen Y, Xu H, Ding L, Wu Z, Xu Z, Wang K. Acute disseminated Talaromyces marneffei in an immunocompetent patient. Mycopathologia. 2017;182(7\u20138):751\u20134.","journal-title":"Mycopathologia"},{"issue":"6","key":"11953_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3892\/mco.2016.1038","volume":"5","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Tao F, Li Y, Xiao Y, Zhang Z, Liu J. Disseminated penicillium Marneffei infection recurrence in a non-acquired immune deficiency syndrome patient: A case report. Mol Clin Oncol. 2016;5(6):829\u201331.","journal-title":"Mol Clin Oncol"},{"issue":"9","key":"11953_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.4103\/0366-6999.180520","volume":"129","author":"HR Li","year":"2016","unstructured":"Li HR, Cai SX, Chen YS, Yu ME, Xu NL, Xie BS, Lin M, Hu XL. Comparison of Talaromyces marneffei infection in human immunodeficiency Virus-positive and human immunodeficiency Virus-negative patients from Fujian, China. Chin Med J (Engl). 2016;129(9):1059\u201365.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"11953_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s15010-021-01679-6","volume":"50","author":"Q Shen","year":"2022","unstructured":"Shen Q, Sheng L, Zhang J, Ye J, Zhou J. Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study. Infection. 2022;50(1):169\u201378.","journal-title":"Infection"},{"issue":"11","key":"11953_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41575-023-00816-w","volume":"20","author":"KS Ost","year":"2023","unstructured":"Ost KS, Round JL. Commensal fungi in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2023;20(11):723\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11953_CR24","doi-asserted-by":"publisher","first-page":"1407893","DOI":"10.3389\/fonc.2024.1407893","volume":"14","author":"X Yu","year":"2024","unstructured":"Yu X, Xu H, Zhou J, Zhu Z, Li B. Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area. Front Oncol. 2024;14:1407893.","journal-title":"Front Oncol"},{"issue":"11","key":"11953_CR25","doi-asserted-by":"publisher","first-page":"e1137","DOI":"10.1097\/CCM.0000000000004581","volume":"48","author":"C Knaak","year":"2020","unstructured":"Knaak C, Schuster FS, Nyvlt P, Spies C, Feinkohl I, Beutel G, Schenk T, La Ros\u00e9e P, Janka G, Brunkhorst FM, et al. Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: A systematic review with pooled analysis. Crit Care Med. 2020;48(11):e1137\u201346.","journal-title":"Crit Care Med"},{"issue":"11","key":"11953_CR26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3899\/jrheum.171325","volume":"45","author":"A Mitander","year":"2018","unstructured":"Mitander A, Fei Y, Trysberg E, Mohammad M, Hu Z, Sakiniene E, Pullerits R, Jin T. Complement consumption in systemic lupus erythematosus leads to decreased opsonophagocytosis in vitro. J Rheumatol. 2018;45(11):1557\u201364.","journal-title":"J Rheumatol"},{"key":"11953_CR27","doi-asserted-by":"publisher","first-page":"703972","DOI":"10.3389\/fimmu.2021.703972","volume":"12","author":"MD Ch\u00e1vez","year":"2021","unstructured":"Ch\u00e1vez MD, Tse HM. Targeting Mitochondrial-Derived reactive oxygen species in T Cell-Mediated autoimmune diseases. Front Immunol. 2021;12:703972.","journal-title":"Front Immunol"},{"issue":"1","key":"11953_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-022-00399-x","volume":"8","author":"MV Lenti","year":"2022","unstructured":"Lenti MV, Luu S, Carsetti R, Osier F, Ogwang R, Nnodu OE, Wiedermann U, Spencer J, Locatelli F, Corazza GR, et al. Asplenia and spleen hypofunction. Nat Rev Dis Primers. 2022;8(1):71.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"11953_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1365-2249.2000.01158.x","volume":"119","author":"N Kudeken","year":"2000","unstructured":"Kudeken N, Kawakami K, Saito A. Mechanisms of the in vitro fungicidal effects of human neutrophils against penicillium Marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). Clin Exp Immunol. 2000;119(3):472\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"11953_CR30","doi-asserted-by":"publisher","first-page":"21169","DOI":"10.1038\/s41598-020-78178-5","volume":"10","author":"K Pruksaphon","year":"2020","unstructured":"Pruksaphon K, Ching MMN, Nosanchuk JD, Kaltsas A, Ratanabanangkoon K, Roytrakul S, Martinez LR, Youngchim S. Characterization of a novel yeast phase-specific antigen expressed during in vitro thermal phase transition of Talaromyces marneffei. Sci Rep. 2020;10(1):21169.","journal-title":"Sci Rep"},{"issue":"1","key":"11953_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","volume":"19","author":"N Vanittanakom","year":"2006","unstructured":"Vanittanakom N, Cooper CR Jr., Fisher MC, Sirisanthana T. Penicillium Marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95\u2013110.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"11953_CR32","doi-asserted-by":"publisher","first-page":"e1007063","DOI":"10.1371\/journal.ppat.1007063","volume":"14","author":"F Ellett","year":"2018","unstructured":"Ellett F, Pazhakh V, Pase L, Benard EL, Weerasinghe H, Azabdaftari D, Alasmari S, Andrianopoulos A, Lieschke GJ. Macrophages protect Talaromyces marneffei conidia from myeloperoxidase-dependent neutrophil fungicidal activity during infection establishment in vivo. PLoS Pathog. 2018;14(6):e1007063.","journal-title":"PLoS Pathog"},{"key":"11953_CR33","doi-asserted-by":"publisher","first-page":"103594","DOI":"10.1016\/j.micpath.2019.103594","volume":"134","author":"S Lu","year":"2019","unstructured":"Lu S, Li D, Xi L, Calderone R. Interplay of interferon-gamma and macrophage polarization during Talaromyces marneffei infection. Microb Pathog. 2019;134:103594.","journal-title":"Microb Pathog"},{"issue":"25","key":"11953_CR34","doi-asserted-by":"publisher","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","volume":"95","author":"CY Chi","year":"2016","unstructured":"Chi CY, Lin CH, Ho MW, Ding JY, Huang WC, Shih HP, Yeh CF, Fung CP, Sun HY, Huang CT, et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections. Med (Baltim). 2016;95(25):e3927.","journal-title":"Med (Baltim)"},{"issue":"8","key":"11953_CR35","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/cid\/cix996","volume":"66","author":"A Aoki","year":"2018","unstructured":"Aoki A, Sakagami T, Yoshizawa K, Shima K, Toyama M, Tanabe Y, Moro H, Aoki N, Watanabe S, Koya T, et al. Clinical significance of Interferon-\u03b3 neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease. Clin Infect Dis. 2018;66(8):1239\u201345.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"11953_CR36","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/cid\/ciaa1086","volume":"72","author":"S Ochoa","year":"2021","unstructured":"Ochoa S, Ding L, Kreuzburg S, Treat J, Holland SM, Zerbe CS. Daratumumab (Anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with Anti-Interferon-\u03b3 autoantibodies. Clin Infect Dis. 2021;72(12):2206\u20138.","journal-title":"Clin Infect Dis"},{"key":"11953_CR37","doi-asserted-by":"publisher","first-page":"100102","DOI":"10.1016\/j.jtauto.2021.100102","volume":"4","author":"JM Rocco","year":"2021","unstructured":"Rocco JM, Rosen LB, Hong GH, Treat J, Kreuzburg S, Holland SM, Zerbe CS. Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies. J Transl Autoimmun. 2021;4:100102.","journal-title":"J Transl Autoimmun"},{"key":"11953_CR38","doi-asserted-by":"publisher","first-page":"1051673","DOI":"10.3389\/fimmu.2022.1051673","volume":"13","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Fang G, Ye F, Zeng W, Tang M, Wei X, Yang J, Li Z, Zhang J. Pathogen spectrum and immunotherapy in patients with anti-IFN-gamma autoantibodies: A multicenter retrospective study and systematic review. Front Immunol. 2022;13:1051673.","journal-title":"Front Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11953-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:22:40Z","timestamp":1763547760000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11953-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11953"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11953-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7534416\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the 900th Hospital of the Joint Logistic Support Force. All procedures involving human participants were conducted in accordance with the ethical standards of this committee and with the principles of the Declaration of Helsinki (\n                      \n                      ). Written informed consent was obtained from the patient included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained written informed consent from the patient, and the clinical details, along with any identifying images, are authorized for publication for academic exchange.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1616"}}